How does context influence the dopamine reward system?

The dopamine system is highly context-dependent and plastic. The same stimulus (e.g., a donut) can be highly rewarding or even aversive depending on factors like hunger, previous experiences, and the current emotional state, demonstrating the brain's ability to rapidly change its response.

Is the rate of dopamine increase linked to a drug's addictive potential?

Yes, the addictive liability of a substance is directly correlated with two aspects of dopamine: the quantity of dopamine released in the nucleus accumbens and the kinetics of its release (how rapidly it occurs). Rapid, powerful surges of dopamine, often influenced by the route of administration, increase addictive potential.

Can a single exposure to an addictive substance cause lasting changes in brain circuitry?

Preclinical rodent studies suggest that a single administration of a drug like cocaine or morphine can cause changes in synaptic connections in reward circuitry that last for several days to weeks, increasing the propensity for addiction if the substance is used again.

Why are social interactions so rewarding from an evolutionary perspective?

Social interactions are highly reinforcing because they evolved as adaptive mechanisms for survival and reproduction. Staying with others of the species increases the likelihood of finding a mate, reproducing, receiving protection from predators, and assisting in child-rearing.

How does social media potentially capitalize on the brain's reward system?

Social media platforms like Instagram and Twitter capitalize on hardwired reward mechanisms by providing intermittent reinforcement. Receiving likes, comments, or messages from friends activates the reward circuitry, stimulating the release of dopamine, serotonin, and oxytocin, making these interactions compelling.

What is the 'social transfer of pain' phenomenon observed in mice?

The social transfer of pain is a phenomenon where a mouse, after spending just one hour with another mouse experiencing modest pain, will begin to manifest behaviors indicating it is also in pain, despite not having experienced any physical injury itself. This involves olfactory cues and the anterior cingulate cortex.

Does MDMA have addictive potential, and how does it compare to other drugs?

MDMA does have some addictive liability because it is an amphetamine derivative and causes dopamine release, which is reinforcing. However, its qualitative experience differs from cocaine or methamphetamine due to its stronger influence on the serotonin system, which is believed to mediate its pro-social effects.

What role do serotonin receptors play in the effects of MDMA and psychedelics?

Serotonin receptors are crucial for the subjective effects of psychoactive drugs. While psychedelics like psilocybin and LSD primarily activate the serotonin 2A receptor, MDMA's pro-social effects are more strongly linked to its interaction with the serotonin 1B receptor, demonstrating how different receptor subtypes lead to vastly different experiences.

What is the current scientific perspective on the therapeutic use of psychedelics and MDMA?

Psychedelics and MDMA are viewed as powerful probes of brain function with potential therapeutic applications, particularly for mental health challenges. However, scientific consensus emphasizes the need for rigorous, sophisticated, and ethical research, cautioning against the belief that they are 'miracle cures' for everyone, and highlighting potential risks of unsupervised use.

Key Moments

How Your Brain’s Reward Circuits Drive Your Choices | Dr. Robert Malenka

Andrew Huberman

Science & Technology2 min read171 min video

Jul 10, 2023|1,227,970 views|11,825|939

andrew huberman huberman lab podcast huberman podcast dr. andrew huberman neuroscience huberman lab andrew huberman podcast the huberman lab podcast science podcast robert malenka stanford school of medicine psychiatry and behavioral sciences

Save to Pod

Key Moments

TL;DR

Dopamine and serotonin reward circuits drive choices; neuroplasticity modifies them. Social interaction and empathy also involve these systems.

Key Insights

Dopamine is a key neuromodulator in the brain's reward circuitry, signaling the importance and salience of environmental stimuli for survival.

The reward system is highly plastic and context-dependent, meaning responses to stimuli can change based on past experiences and current circumstances.

Addiction involves potentiation of dopamine release, especially with rapid administration routes, leading to significant changes in neural circuits.

Social interactions are highly rewarding, involving dopamine, serotonin, and oxytocin, and are crucial for species survival and well-being.

Empathy and compassion have neurobiological underpinnings that can be studied, suggesting potential therapeutic targets for conditions like autism.

MDMA's effects on prosocial behavior are primarily linked to serotonin release, while its potential for addiction relates more to dopamine.

THE FUNDAMENTAL ROLE OF DOPAMINE

Dopamine, a critical neuromodulator, is central to the brain's reward circuitry. Its primary function is to signal the importance and salience of environmental stimuli, motivating behaviors that enhance survival and reproduction. This system evolved to help us identify and repeat actions associated with beneficial outcomes, such as consuming nutritious food or engaging in social activities.

NEUROPLASTICITY AND CONTEXTUAL INFLUENCES

The dopamine reward system is not static; it's highly plastic and profoundly influenced by context. Past experiences, environmental cues, and internal states (like hunger or satiety) significantly alter how the brain responds to stimuli. For example, a highly desirable food can become aversive when one is full, demonstrating the dynamic nature of reward processing.

ADDICTION: TRICKING THE REWARD SYSTEM

Addictive substances and behaviors hijack the reward circuitry by causing unnaturally large and rapid surges of dopamine. This potentiation, particularly with fast routes of administration like smoking or injection, triggers powerful neuroplastic changes that reinforce drug-seeking behavior. The rapid onset and intense dopamine release are key factors contributing to a drug's addictive liability, often leading to a cycle of wanting without necessarily liking the experience.

THE NEUROBIOLOGY OF SOCIAL CONNECTION

Positive social interactions are intrinsically rewarding and play a vital role in human well-being and survival. These experiences engage the reward system, involving dopamine, serotonin, and oxytocin. This circuitry evolved to promote prosocial behaviors, fostering cooperation, reproduction, and protection, highlighting our nature as social beings.

EMPATHY AND ITS NEURAL BASIS

Empathy and compassion, essential components of positive social interaction, are being investigated for their neurobiological underpinnings. Research using animal models suggests that behaviors indicative of empathy, such as experiencing pain relief by associating with a calm individual or exhibiting concern for another's distress, involve complex brain circuits, including the anterior cingulate cortex and its projections to the nucleus accumbens.

THERAPEUTIC POTENTIAL OF NEUROMODULATORS

Understanding the roles of dopamine, serotonin, and oxytocin in reward and social behavior opens avenues for therapeutic interventions. While intranasal oxytocin has shown limited success for social deficits in autism, research into drugs like MDMA, which significantly impacts serotonin and dopamine systems, reveals potential for prosocial and empathic enhancement. Further investigation into these neuromodulatory systems may lead to novel treatments for conditions affecting social interaction and emotional processing.

Mentioned in This Episode

●Supplements

●Products

●Software & Apps

●Companies

●Organizations

●Books

●Concepts

●People Referenced

Common Questions

Dopamine is a major neuromodulator in the brain's reward circuitry, signaling that a stimulus or experience is reinforcing or important for survival. It drives behaviors that lead to rewarding experiences and helps us remember both positive and negative events.

Topics

Psychedelics Neuroscience & the Brain Mental Health & Psychology Mindset & Self-Improvement Autism Spectrum Disorder Social Cognition Reward System

Mentioned in this video

Companies

ROKA

Company that makes high-quality eyeglasses and sunglasses, founded by two All-American swimmers from Stanford, designed for performance but also suitable for everyday use.

Maplight Therapeutics

A small biotech company co-founded by Dr. Malenka and Carl Deisseroth, developing drugs that target serotonin receptors for conditions including autism.

Levels

A program that provides real-time feedback on health by using a continuous glucose monitor to track how foods and behaviors affect blood glucose levels.

MindMed

A publicly traded psychedelic company with a scientific advisory board including Dr. Malenka, gearing up for trials of specific forms of MDMA.

Supplements

Opioids

A class of drugs including morphine and heroin, which cause massive dopamine release through indirect mechanisms, leading to high addictive liability.

Element

An electrolyte drink containing sodium, magnesium, and potassium without sugar, used for hydration and supporting nerve and cell function.

Methamphetamine

A powerful psychoactive stimulant, similar to cocaine in its rapid and potent dopamine release, with high addictive liability.

Cocaine

A psychoactive stimulant drug with high addictive liability, known for causing a rapid, powerful surge of dopamine.

AG1

A daily vitamin, mineral, and probiotic drink with adaptogens, designed to meet foundational nutrition needs and support energy, focus, and sleep.

Ibogaine

A complex psychoactive substance being studied for its potential therapeutic effects, with funding allocated for its research by the state of Kentucky.

People

Roger Nicoll

Dr. Malenka's postdoctoral mentor at UCSF, known for his work on mechanisms of synaptic plasticity.

Kent Berridge

A prominent researcher in the addiction field who, with Terry Robinson, distinguished between the concepts of 'wanting' and 'liking' in reward.

Larry Young

A well-known researcher in social behavior and bonding, particularly for his work on prairie voles and the role of oxytocin in pair bonding.

Andrew Huberman

Host of the Huberman Lab podcast and professor of neurobiology and ophthalmology at Stanford School of Medicine.

Alan Hobson

Emeritus Professor of Psychiatry at Harvard Medical School, known for his research on sleep, dreaming, and hallucinations.

Terry Robinson

A prominent researcher in the addiction field who, with Kent Berridge, distinguished between the concepts of 'wanting' and 'liking' in reward.

Monique Smith

A scientist who joined Dr. Malenka's lab, now an assistant professor at UCSD, and who introduced behavioral assays for studying empathy in mice.

Robert Malenka

Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, an MD and PhD researcher, known for discoveries in neuroplasticity, reward systems, dopamine, and more recently, autism and psychedelics.

Carl Deisseroth

A prominent Stanford neuroscientist, trained in Dr. Malenka's laboratory, known for pioneering optogenetics.

Anna Lembke

Colleague of Dr. Malenka and Andrew Huberman, a psychiatrist specializing in addiction and author of 'Dopamine Nation'.

Rick Doblin

Founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), credited for his long-term efforts to promote legal, scientific study of MDMA.

Products

Blue Lotus Flower Tea

A tea containing morphine-like compounds that can induce bizarre dreams and prolonged sleep, which is illegal in the United States.

Continuous Glucose Monitor

A device used by Levels to give real-time feedback on blood glucose levels, helping users optimize diet and exercise.

Drugs & Medications

dextromethorphan

A type of opioid found in cough syrup, which some people can develop a problem with due to its psychoactive effects.

Prozac

A traditional serotonergic drug (SSRI) that has been tested for utility in autism spectrum disorder but has not shown efficacy in well-controlled clinical trials.

Lysergic Acid Diethylamide

A classic hallucinogen that largely works through activation of the serotonin 2A receptor, leading to mystical subjective effects.

psilocybin

A classic hallucinogen, similar to LSD, that largely works through activation of the serotonin 2A receptor, leading to mystical subjective effects.

MDMA

A drug that profoundly increases dopamine and serotonin transmission, being studied for its pro-social and empathogenic effects, particularly in psychotherapy for PTSD.

Organizations

Stanford University School of Medicine

Academic institution where Dr. Huberman and Dr. Malenka are professors, and where much of the discussed research takes place.

Science (journal)

A prestigious scientific journal in which Dr. Malenka's lab published a paper on the social transfer of pain in mice.

Multidisciplinary Association for Psychedelic Studies

An organization that has pioneered rigorous and ethical study of MDMA, particularly as an adjunct to psychotherapy for PTSD, and is conducting trials for other conditions.

Concepts

Oxytocin

An evolutionarily conserved neuropeptide important for parturition, milk production, and social bonding, sometimes referred to as the 'love neuropeptide'.